New eye drops aim to boost blood flow in diabetic retinopathy and glaucoma
Disease control
Recruiting now
This early study tests whether QLS-111 eye drops can improve blood flow to the back of the eye in people with non-proliferative diabetic retinopathy or certain types of glaucoma. Fourteen participants will use the drops twice daily for two weeks. The main goal is to measure chang…
Phase: PHASE2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC